Explore 3 Stock Ideas & Industry Insights Download Free Report

888-969-2592
Shopping Cart 0
countryflagCA
Login

Home CompaniesTelyRx Holdings Inc.

TelyRx Holdings Inc.

Healthcare Pharmaceutical Retailers
PortfolioPortfolio WatchlistWatchlist
Company price
2.55 CAD 0.05 ( 2.00%)
Last update at 2026-11-04T20:00:00Z
VOLUME
2751
Market Cap
170.98M

Momentum Score

…

TelyRx Holdings Inc. operates as a vertically integrated technology-enabled healthcare and pharmacy services company which develops and operates a digital pharmacy platform. Its platform connects patients nationwide with physicians for access to everyday prescriptions. The company also operates pharmacies which ship the medicine to the patient's door with next-day delivery. It caters to doctors, veterinarians, practice groups, and other licensed prescribers. The company was founded in 2022 and is based in Clearwater, Florida.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
2.50
Low
2.70
High
52 Week Price Range
3.00
Low
4.25
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High
AI Summary

TelyRx Holdings Inc. is a publicly listed company (TELY.TO) for which publicly available disclosures are limited, so its core business activities and financial profile are not clearly described in accessible filings. Because operational details are sparse, long-term growth drivers are not identifiable from public information; investors may find the company attractive only if future disclosure clarifies strategy or demonstrates sustainable revenue and execution.

Risk Score
High

Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.

Key Metrics*

Previous Close
2.50
Dividend Yield
-
Revenue TTM
33.30M
Revenue Per Share
3.17
Gross Profit TTM
15.62M
Debt / Equity
-
ROE
-
Net Debt
3.90M
ROCE
-30.20%
Diluted EPS TTM
-0.09

Insight News

View All

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-12-31 2024-12-31 2023-12-31
Type yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31
Income before tax -0.42M -4.83M -1.64M
Net income -0.42M -13.48M -4.39M
Selling general administrative 0.44M 6.20M 0.46M
Gross profit - 3.51M 0.00M
Reconciled depreciation - 0.20M 0.03M
Operating income -0.44M -3.93M -0.75M
Interest expense - 0.93M 0.89M
Interest income 0.01M - -
Net interest income - -0.93M -0.89M
Total revenue 0.00M 9.53M 0.03M
Total operating expenses 0.44M 13.46M 0.77M
Cost of revenue - 6.02M 0.03M
Total other income expense net - 0.03M -
Net income from continuing ops - -4.83M -1.64M
Net income applicable to common shares -0.42M - -
Breakdown 2025-12-31 2024-12-31 2023-12-31
Type yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31
Total assets 1.51M 7.95M 11.90M
Intangible assets - 0.64M 0.29M
Total liab 0.06M 10.99M 13.54M
Total stockholder equity 1.45M -3.05M -1.64M
Other current liab - - 5.73M
Common stock 1.57M - -
Capital stock - 15.91M 3.84M
Retained earnings -0.42M -18.96M -5.48M
Cash 1.51M 3.31M 0.23M
Total current liabilities 0.06M 1.55M 6.97M
Net debt - 3.90M 5.33M
Short term debt 0.00M - -
Short long term debt - - 0.06M
Other stockholder equity 0.31M - -
Total current assets 1.51M 4.77M 10.47M
Net receivables - 0.38M 0.00M
Long term debt - 7.21M 5.50M
Inventory - 0.46M 0.06M
Accounts payable - 0.94M 0.11M
Non current assets total - 3.18M 1.44M
Capital lease obligations - 2.32M 1.13M
Long term debt total 0.00M - -
Breakdown 2025-12-31 2024-12-31 2023-12-31
Type yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31
Investments - -0.44M 0.00M
Net borrowings - 0.73M 0.06M
Total cash from financing activities 1.62M 7.28M 0.35M
Net income -0.42M -13.48M -4.39M
Change in cash 1.51M 2.88M -2.56M
Begin period cash flow 3.31M 0.44M 3.00M
End period cash flow - 3.31M 0.44M
Total cash from operating activities -0.11M -2.92M -2.47M
Issuance of capital stock - 6.55M 0.29M
Depreciation - 0.20M 0.03M
Change to inventory - -0.40M -0.06M
Change to account receivables - -0.38M -0.00M
Sale purchase of stock 1.62M - -
Capital expenditures 0.00M 0.74M 0.36M
Change in working capital 0.06M 0.21M -0.30M
Stock based compensation - 3.20M 0.00M
Other non cash items - 0.99M 0.95M
Free cash flow - -3.66M -2.83M

Peer Comparison*

Sector: Healthcare Industry: Pharmaceutical Retailers

Stock Name
Change
(CAD)
Price
(CAD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
TELY
TelyRx Holdings Inc.		 0.05
2.00%		 2.55 - - 5.14 - 2.27

Profile*

TelyRx Holdings Inc.

TelyRx Holdings Inc. operates as a vertically integrated technology-enabled healthcare and pharmacy services company which develops and operates a digital pharmacy platform. Its platform connects patients nationwide with physicians for access to everyday prescriptions. The company also operates pharmacies which ship the medicine to the patient's door with next-day delivery. It caters to doctors, veterinarians, practice groups, and other licensed prescribers. The company was founded in 2022 and is based in Clearwater, Florida.

24761 US Hwy 19N, Clearwater, FL, United States, 33763

(800) 878-1660

https://TelyRx.com

Name Title Year Born
Ms. Vanessa Slowey President, CEO & Director 1969
Mr. Adam Gardner Chief Operating Officer NA
Mr. John Eustice Secretary & General Counsel NA
Mr. Peter Lloyd Chief Revenue Officer NA
Mr. Rafael Jose Chief Digital Officer NA

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Kalkine

3 Mining Stock
Ideas Report

Download a free report with stock ideas and industry insights for general information.

Download Free Report Now → sector image

Top Stocks by Market Cap*

PRL
CAD 30.50
+15.05%
DSV
CAD 11.02
+14.55%
USA
CAD 4.29
+13.19%
NUAG
CAD 7.70
+12.90%
GMIN
CAD 43.79
+12.86%
DRUG
CAD 26.11
-29.58%
HUT
CAD 68.98
-22.41%
UCU
CAD 2.09
-14.34%
VET
CAD 14.87
-14.29%
PHX
CAD 10.96
-13.56%

Equity Sectors*

  • Basic Materials

    +5.46%

  • Communication Services

    +3.38%

  • Consumer Cyclical

    +3.11%

  • Consumer Defensive

    +1.35%

  • Energy

    -4.79%

  • Financial Services

    +2.66%

  • Healthcare

    -0.72%

  • Industrials

    -0.11%

  • Real Estate

    +1.84%

  • Technology

    +1.05%

  • Utilities

    +0.39%

Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.

Support

Hi! How can we help you today?

Loading…